Rabeprazole Sodium Tablet, Delayed Release
NDC Package 72888-059-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Rabeprazole Sodium tablets is rabeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). This formulation utilizes a tablet, delayed release delivery system. Marketed by Advagen Pharma Limited, this product is identified by NDC 72888-059 and is authorized under FDA application ANDA204237.

Identification & Billing

NDC Package Code
72888-059-90
Package Description
90 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
72888-059
11-Digit Billing Format
72888005990
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk
  • RxCUI: 854868 - RABEprazole sodium 20 MG Delayed Release Oral Tablet
  • RxCUI: 854868 - rabeprazole sodium 20 MG Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Rabeprazole Sodium
Non-Proprietary Name
Rabeprazole Sodium
Substance Name
Rabeprazole Sodium
Dosage Form
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
RABEPRAZOLE SODIUM 20 mg/1
Pharmacologic Class
Usage Information
Rabeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Rabeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Advagen Pharma Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA204237
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-01-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72888-059). Click a package code to view its specific billing and regulatory data.

72888-059-30
30 TABLET, DELAYED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72888-059-90 identifies a specific commercial package of 90 tablet, delayed release in 1 bottle of Rabeprazole Sodium, a human prescription drug labeled by Advagen Pharma Limited. This tablet, delayed release is formulated for oral use and contains rabeprazole sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advagen Pharma Limited on June 01, 2017. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Rabeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Rabeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Advagen Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72888005990. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72888-059-90
11-Digit CMS (5-4-2)
72888-0059-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.